SBC Medical Group (NASDAQ:SBC) Reaches New 1-Year High - What's Next?

Key Points

• SBC Medical Group shares reached a new 52-week high, trading as high as $5.61 and recently changing hands near $5.40. The stock’s 50-day and 200-day moving averages were $4.31 and $3.69, respectively.
• Analysts maintain a generally positive outlook, with two Buy ratings and one Hold rating producing a “Moderate Buy” consensus and an average price target of $8.50.
• The company beat revenue expectations with quarterly sales of $49.19 million but missed earnings estimates, reporting $0.10 per share versus $0.12 expected. Institutional investors own approximately 60.82% of the stock.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report)'s share price hit a new 52-week high on Tuesday. The company traded as high as $5.61 and last traded at $5.4040, with a volume of 39,904 shares traded. The stock had previously closed at $5.39.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Wall Street Zen raised SBC Medical Group from a "buy" rating to a "strong-buy" rating in a research note on Monday, October 5th. BTIG Research reaffirmed a "buy" rating and set a $8.00 target price on shares of SBC Medical Group in a research note on Thursday, August 13th. Finally, Weiss Ratings upgraded SBC Medical Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $8.50.

SBC Medical Group Price Performance

The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The firm has a market capitalization of $544.69 million, a price-to-earnings ratio of 11.29, a PEG ratio of 2.44 and a beta of 0.56. The business's fifty day simple moving average is $4.31 and its 200 day simple moving average is $3.69.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.02). The company had revenue of $49.19 million for the quarter, compared to analyst estimates of $45.37 million. SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. On average, research analysts forecast that SBC Medical Group Holdings Incorporated will post 0.44 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in SBC. Citadel Advisors LLC bought a new position in SBC Medical Group in the second quarter worth approximately $446,000. BlackRock Inc. bought a new stake in shares of SBC Medical Group during the second quarter valued at approximately $2,846,000. Williams & Novak Wealth Management LLC increased its holdings in shares of SBC Medical Group by 40.9% during the third quarter. Williams & Novak Wealth Management LLC now owns 26,330 shares of the company's stock valued at $130,000 after acquiring an additional 7,644 shares in the last quarter. State Street Corp raised its position in shares of SBC Medical Group by 59.7% during the second quarter. State Street Corp now owns 49,239 shares of the company's stock worth $152,000 after purchasing an additional 18,400 shares during the period. Finally, Bank of America Corp DE acquired a new position in shares of SBC Medical Group during the second quarter worth approximately $35,000. 60.82% of the stock is owned by institutional investors and hedge funds.

About SBC Medical Group

SBC Medical Group Holdings Incorporated NASDAQ: SBC is a healthcare company focused on supporting medical institutions, particularly clinics that provide aesthetic and cosmetic medical treatments. Its business includes management services, operational support and products designed to help medical providers deliver care and manage their practices.

The company is associated with the Shonan Beauty Clinic network, which offers services such as cosmetic surgery, dermatology, hair restoration and other aesthetic procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.